Responses
Clinical/translational cancer immunotherapy
Original research
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.